{"id":"https://genegraph.clinicalgenome.org/r/aaab4f69-21a2-47d1-ab11-bcef26a53b4dv1.0","type":"EvidenceStrengthAssertion","dc:description":"*SPATA13* was first reported in relation to autosomal dominant primary angle closure glaucoma (PACG)  in 2020 (Waseem et al., PMID: 32339198). PACG disorders include physical obstruction of the aqueous humor outflow channels, elevation of internal eye pressure, ocular hypertension, plateau iris configuration, iridocorneal angle closure, drainage angle damage, and end-organ glaucomatous damage. *SPATA13 *contains 1,339 amino acids and 14 exons, and functions as a guanine nucleotide exchange factor. There is only one disease assertion made for *SPATA13*; Primary Angle Closure Glaucoma (618880).\nSummary of Genetic Evidence (2.1 points): One 9-base-pair deletion was found in all affected individuals (n=12) from one family in one publication (PMID: 32339198). The mechanism of pathogenicity appears to be loss of function. \nSummary of Experimental Evidence (0 points): This gene-disease relationship is supported by an expression study (PMID: 32339198) revealing expression of SPATA13 in eye tissue including the human iris, ciliary epithelium, retinal pigment epithelium, retina and lens; however, the study also suggested a ubiquitous expression pattern of *SPATA13,* confirmed by GTex (https://gtexportal.org/home/gene/SPATA13). In summary, there is limited evidence to support this gene-disease relationship. Although more evidence is needed to support a causal role, no convincing evidence has emerged that contradicts the gene-disease relationship.\n","dc:isVersionOf":"https://genegraph.clinicalgenome.org/r/aaab4f69-21a2-47d1-ab11-bcef26a53b4d","GCISnapshot":"https://genegraph.clinicalgenome.org/r/5ef1d5a1-5a5b-425b-998d-0c6e23d3bd40","calculatedEvidenceStrength":"Limited","contributions":[{"id":"https://genegraph.clinicalgenome.org/r/5ef1d5a1-5a5b-425b-998d-0c6e23d3bd40_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10077","date":"2023-03-16T19:00:00.000Z","role":"Approver"},{"id":"https://genegraph.clinicalgenome.org/r/5ef1d5a1-5a5b-425b-998d-0c6e23d3bd40_publish_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10077","date":"2023-03-30T19:07:58.615Z","role":"Publisher"}],"evidence":[{"id":"https://genegraph.clinicalgenome.org/r/5ef1d5a1-5a5b-425b-998d-0c6e23d3bd40_experimental_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/5ef1d5a1-5a5b-425b-998d-0c6e23d3bd40_functional_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/a44ca6ef-3f9e-4f55-afc8-12fe27b32a7a","type":"EvidenceLine","dc:description":"Ubiquitous expression (not just eye)","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/3b222615-b107-45b1-be1d-73a16075465d","type":"Finding","dc:description":"Researchers investigated expression levels of two transcripts of SPATA13\nNM_001166271;NP_001159743 (1277 amino acids) and NM_153023;NP_694568 (652 amino acids) in seventeen different human cell lines derived from the eye. They found expression of both SPATA13 transcripts in the human iris, ciliary epithelium, retinal pigment epithelium, retina and lens\n","dc:source":"https://pubmed.ncbi.nlm.nih.gov/32339198","rdfs:label":"Waseem_Expression_Experiment","demonstrates":{"id":"cg:GeneExpressionA"}}],"specifiedBy":"GeneValidityGeneExpressionCriteria","strengthScore":0}],"specifiedBy":"GeneValidityOverallFunctionalEvidenceCriteria","strengthScore":0}],"specifiedBy":"GeneValidityOverallExperimentalEvidenceCriteria","strengthScore":0},{"id":"https://genegraph.clinicalgenome.org/r/5ef1d5a1-5a5b-425b-998d-0c6e23d3bd40_overall_genetic_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/66931cc3-925b-4673-a48e-9e76a233e7bd","type":"EvidenceLine","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/66931cc3-925b-4673-a48e-9e76a233e7bd_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/32339198","allele":{"id":"https://genegraph.clinicalgenome.org/r/a237dfb7-4eb7-46ef-b631-0a42de732a0a","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001166271.3(SPATA13):c.1432_1440del (p.Gln478_Pro480del)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA6913914"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/5ef1d5a1-5a5b-425b-998d-0c6e23d3bd40_seg_el","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/8d4348ab-b94a-4efd-b61e-5a600da1dd88_proband_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/32339198","rdfs:label":"Waseem_Family_1","family":{"id":"https://genegraph.clinicalgenome.org/r/8d4348ab-b94a-4efd-b61e-5a600da1dd88","type":"Family","rdfs:label":"Waseem_Family_1","ethnicity":{"id":"cg:NotHispanicOrLatino"},"member":{"id":"https://genegraph.clinicalgenome.org/r/b18fc099-e88b-407b-8570-ef0289e204e1","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/32339198","rdfs:label":"Waseem_Proband_V:8","allele":{"id":"https://genegraph.clinicalgenome.org/r/a237dfb7-4eb7-46ef-b631-0a42de732a0a"},"sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/66931cc3-925b-4673-a48e-9e76a233e7bd_variant_evidence_item"}}},"meetsInclusionCriteria":true,"phenotypeFreeText":"ocular hypetension, plateau iris configuration, primary angle closure glaucoma","phenotypePositiveAllelePositive":4,"phenotypes":["obo:HP_0007906","obo:HP_0000501"],"proband":{"id":"https://genegraph.clinicalgenome.org/r/b18fc099-e88b-407b-8570-ef0289e204e1"},"publishedLodScore":3.76,"sequencingMethod":{"id":"cg:AllGenesSequencing"}}],"specifiedBy":"GeneValiditySegregationEvidenceCriteria","strengthScore":2}],"specifiedBy":"GeneValidityOverallGeneticEvidenceCriteria","strengthScore":2.1}],"evidenceStrength":"Limited","sequence":6037,"specifiedBy":"GeneValidityCriteria9","strengthScore":2.1,"subject":{"id":"https://genegraph.clinicalgenome.org/r/SM7XusT3n2A","type":"GeneValidityProposition","disease":"obo:MONDO_0001868","gene":"hgnc:23222","modeOfInheritance":"obo:HP_0000006"},"version":"1.0","websiteLegacyID":"https://genegraph.clinicalgenome.org/r/assertion_5ef1d5a1-5a5b-425b-998d-0c6e23d3bd40-","@context":{"@vocab":"https://genegraph.clinicalgenome.org/terms/","id":"@id","type":"@type","cg":"https://genegraph.clinicalgenome.org/terms/","dc":"http://purl.org/dc/terms/","obo":"http://purl.obolibrary.org/obo/","hgnc":"https://identifiers.org/hgnc:","rdfs":"http://www.w3.org/2000/01/rdf-schema#","cggv":"https://genegraph.clinicalgenome.org/r/gci/","evidenceStrength":{"@type":"@vocab"},"calculatedEvidenceStrength":{"@type":"@vocab"},"computedEvidenceStrength":{"@type":"@vocab"},"specifiedBy":{"@type":"@vocab"},"evidence":{"@container":"@set"},"disease":{"@type":"@vocab"},"gene":{"@type":"@vocab"},"phenotypes":{"@type":"@id"},"agent":{"@type":"@id"},"role":{"@type":"@vocab"},"modeOfInheritance":{"@type":"@vocab"},"sex":{"@type":"@vocab"},"direction":{"@type":"@vocab"},"ageType":{"@type":"@vocab"},"ageUnit":{"@type":"@vocab"},"dc:source":{"@type":"@id"},"curationReasons":{"@type":"@vocab","@container":"@set"},"GCISnapshot":{"@type":"@id"},"dc:isVersionOf":{"@type":"@id"},"websiteLegacyID":{"@type":"@id"}}}